Barclays’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.8M Buy
92,871
+47,874
+106% +$6.58M ﹤0.01% 1017
2025
Q1
$8.11M Sell
44,997
-7,432
-14% -$1.34M ﹤0.01% 1136
2024
Q4
$8.21M Sell
52,429
-4,111
-7% -$644K ﹤0.01% 1245
2024
Q3
$10.3M Buy
56,540
+37,452
+196% +$6.82M ﹤0.01% 1034
2024
Q2
$3.51M Sell
19,088
-2,526
-12% -$464K ﹤0.01% 1351
2024
Q1
$3.85M Sell
21,614
-42,565
-66% -$7.57M ﹤0.01% 1516
2023
Q4
$7.96M Buy
64,179
+24,659
+62% +$3.06M ﹤0.01% 1186
2023
Q3
$4.58M Sell
39,520
-7,107
-15% -$824K ﹤0.01% 1180
2023
Q2
$5.47M Buy
46,627
+16,734
+56% +$1.96M ﹤0.01% 1183
2023
Q1
$2.39M Sell
29,893
-6,455
-18% -$517K ﹤0.01% 1527
2022
Q4
$2.88M Buy
36,348
+3,217
+10% +$255K ﹤0.01% 1422
2022
Q3
$2.31M Buy
33,131
+31,925
+2,647% +$2.22M ﹤0.01% 1556
2022
Q2
$79K Sell
1,206
-2,189
-64% -$143K ﹤0.01% 3559
2022
Q1
$225K Sell
3,395
-22,466
-87% -$1.49M ﹤0.01% 3238
2021
Q4
$1.81M Buy
25,861
+13,161
+104% +$920K ﹤0.01% 1867
2021
Q3
$663K Buy
12,700
+9,334
+277% +$487K ﹤0.01% 2466
2021
Q2
$228K Sell
3,366
-18,655
-85% -$1.26M ﹤0.01% 2833
2021
Q1
$1.7M Sell
22,021
-2,914
-12% -$225K ﹤0.01% 2001
2020
Q4
$1.5M Sell
24,935
-1,759
-7% -$106K ﹤0.01% 1752
2020
Q3
$1.15M Buy
26,694
+19,890
+292% +$857K ﹤0.01% 1837
2020
Q2
$282K Sell
6,804
-2,516
-27% -$104K ﹤0.01% 2637
2020
Q1
$402K Sell
9,320
-1,487
-14% -$64.1K ﹤0.01% 2222
2019
Q4
$598K Buy
10,807
+329
+3% +$18.2K ﹤0.01% 2592
2019
Q3
$364K Sell
10,478
-460
-4% -$16K ﹤0.01% 2781
2019
Q2
$440K Sell
10,938
-25,048
-70% -$1.01M ﹤0.01% 2784
2019
Q1
$1.18M Sell
35,986
-1,403
-4% -$46.2K ﹤0.01% 2022
2018
Q4
$777K Buy
+37,389
New +$777K ﹤0.01% 1990